Response-Based Ponatinib Dose Reduction a Win-Win in Chronic-Phase CML?
For patients with chronic-phase chronic myeloid leukemia (CML), a response-based dose-reduction strategy for ponatinib (Iclusig)…
Browsing Tag
CML
Can Dasatinib Dose Be Halved in Low-Risk CML?
ATLANTA -- Using a lower dose of dasatinib (Sprycel) for the initial treatment of chronic myeloid leukemia (CML) in chronic phase…